Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA®) in active ulcerative colitis
-Results of a new study 1 presented today at the United European Gastroenterology Week (UEGW) congress in Stockholm demonstrate…
Ferring Pharmaceuticals acquires Cytokine PharmaSciences Inc.
-Ferring Pharmaceuticals (Ferring) announced today that it has completed the purchase of Cytokine PharmaSciences Inc. (CPSI) and its…
The untold impact of childhood bedwetting in later life
-New data, presented today at the International Continence Society (ICS) congress in Glasgow1, suggest that bedwetting…
New research reveals night-time toilet trips are not a trivial problem
-New data, presented at the International Continence Society (ICS) Congress, highlight the significant detrimental impact of nocturia…
New data demonstrating long-term benefits of FIRMAGON® (degarelix) for advanced hormone-dependant prostate cancer published in The Journal of Urology
-New data, published in the September issue of The Journal of Urology, showed that long-term use of FIRMAGON®…
Archives Press release 2011
Archives Press release 2011